Tomáš Cihlář

Tomáš Cihlář

virologist Czech Republic

Tomáš Cihlář is a Czech virologist and biochemist known for his leadership in the biology department at Gilead Sciences. He has been instrumental in the development of groundbreaking antiviral medications, including Lenacapavir, a newly approved injection for HIV prevention. His work has significantly advanced efforts to combat viral infections, including the development of remdesivir during the COVID-19 pandemic.

Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
0
Power
0$
Sentiment
0.00
Countries Mentioned

No country-level mention data available.

Interactive World Map

Each country's color is based on "Mentions" from the table above.

Recent Mentions

Slovakia Slovakia: Tomáš Cihlář is a Czech virologist and biochemist who leads the biology department at Gilead Sciences and contributed to the development of the drug remdesivir during the COVID-19 pandemic. 8

SME – major Slovak daily, est. 1993: Americký úrad schválil injekciu na prevenciu HIV